Draig Therapeutics Showcases Positive Phase 1 DT-101 Data at ASCP Annual Meeting
Draig Therapeutics Highlights Positive Phase 1 DT-101 Results at ASCP Annual Meeting American Society for Clinical Psychopharmacology served as the stage for new clinical and translational data from Draig Therapeutics, which unveiled encouraging findings from its Phase 1 clinical development…